Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atherosclerosis in dialyzed patients.

Eberhard Ritz1

  • 1University of Heidelberg, Department of Nephrology, Heidelberg, Germany. prof.e.ritz@t-online.de

Blood Purification
|January 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Ischemic heart disease is the leading cause of death in dialysis patients. Beyond traditional factors, microinflammation and disturbed phosphate metabolism are key contributors to accelerated atherosclerosis in these individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular disease (CVD) mortality is high in dialysis patients, particularly in Europe.
  • Ischemic heart disease (IHD) is the primary cause of death among patients undergoing dialysis, as indicated by the HEMO study.
  • The etiology of accelerated atherosclerosis in dialysis patients is debated, involving both traditional and non-traditional risk factors.

Purpose of the Study:

  • To investigate the multifactorial causes of accelerated atherosclerosis in patients on dialysis.
  • To elucidate the role of non-traditional risk factors in the high incidence of IHD in dialyzed patients.

Main Methods:

  • Analysis of data from the HEMO study.
  • Review of existing literature on cardiovascular risk factors in dialysis patients.

Related Experiment Videos

  • Comparison of traditional and non-traditional risk factors associated with atherosclerosis.

    • Main Results:

    • Ischemic heart disease is the most frequent cause of death in patients undergoing dialysis.
    • Non-traditional risk factors, including microinflammation, elevated asymmetrical dimethyl-L-arginine, phosphate metabolism disturbances, and anemia, are increasingly recognized as significant contributors.
    • These factors, alongside classic risk factors like hypertension, dyslipidemia, and diabetes, drive accelerated atherosclerosis.

    Conclusions:

    • The high prevalence of atherosclerotic manifestations in dialysis patients is attributed to a combination of traditional and non-traditional risk factors.
    • Microinflammation, disturbed phosphate metabolism, and other non-traditional factors play a crucial role in accelerating atherosclerosis.
    • Addressing these comprehensive risk factors is essential for managing cardiovascular health in dialysis populations.